ALKS vs MAS · P/E 14, rev $1.56B vs P/E 18, rev $7.83B
Alkermes Plc (ALKS) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ALKS and MAS stock pages for the full models.
Not investment advice.